40 completed, 31 unknown, 24 recruiting, 14 terminated. 135 Phase 2, 32 Phase 1, 17 Phase 3.
Follow Fecal Microbiota Transplantation: new trials by email Literature Review of Fecal Microbiota Transplantation trials Research Report on Fecal Microbiota Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ecosystem Nourishment for Gut Restoration After Fecal Transplantation Fecal Microbiota Transplant Capsules, Microbiome Rejuvenating Diet, Placebo Fecal Microbiota Transplantation - Aging | Phase 2 | Not yet recruiting | Stanford University | 80 | 2026-12-01 | 2026-09-17 |
| Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC Tislelizumab, Fecal Microbiota Transplant(FMT) - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Se-Hoon Lee | 15 | 2026-09-30 | 2026-08-11 |
| A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD Fecal Microbiota Transplant (FMT), Nitazoxanide 500mg BID, Vancomycin 250mg BID - ADHD, ADHD - Attention Deficit Disorder With Hyperactivity | Phase 2 | Not yet recruiting | University of Calgary | 64 | 2026-08-31 | 2026-09-10 |
| Safety and Feasibility of FMT for Immune Recovery After HSCT Fecal microbiota transplantation (FMT) - Humoral Immunodeficiency, Hematopoietic Stem Cell Transplantation | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 86 | 2026-08-01 | 2026-08-12 |
| Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial Fecal Microbiota Transplantation (FMT) Capsules, Placebo capsules - Heart Failure With Preserved Ejection Fraction (HFPEF), Chronic Heart Failure | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Air Force Medicial University | 50 | 2026-06-01 | 2026-06-05 |
| Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation Fecal microbiota transplantation (FMT), Sham-transplantation (placebo) - Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD) | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 72 | 2026-05-01 | 2026-03-17 |
| Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia FMT capsule - Cachexia; Cancer, Fecal Microbiota Transplantation (FMT) | Phase 2 | Not yet recruiting | Hua Jiang | 66 | 2026-05-01 | 2026-04-16 |
| Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined. Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells, Fecal Biomicrome Transplantation (FMT), Ketogenic RESET Diet Protocol - Autism Spectrum Disorder, Autism | Phase 1 / Phase 2 | Enrolling by invitation | Black Tie Medical, Inc. | 50 | 2026-04-30 | 2026-04-27 |
| Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD Fecal microbiota transplantation (FMT) - Graft vs Host Disease | Phase 2 | Recruiting | Chang Gung Memorial Hospital | 35 | 2026-04-29 | 2026-05-22 |
| PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy Tislelizumab Combined With TKI, Fecal Microbiota Transplantation, PULSAR - Hepatocellular Carcinoma (HCC) | Phase 2 | Recruiting | Wang Xin | 64 | 2026-04-15 | 2026-09-02 |
| Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome FMT capsule, Placebo - Irritable Bowel Syndrome (IBS) | Phase 1 / Phase 2 | Recruiting | University of Rijeka | 70 | 2026-03-15 | 2026-03-18 |
| Evaluation of the Outcome of Fecal Microbiota Transplantation Fecal Microbiota Transplantation, FMT Matched Placebo, Rifaximin、Lactulose - Hepatic Encephalopathy, Fecal Microbiota Transplantation | Phase 1 / Phase 2 | Not yet recruiting | Air Force Military Medical University, China | 40 | 2026-03-07 | 2026-03-06 |
| Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells Axicabtagene Ciloleucel, Biospecimen Collection, Chemotherapy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | Recruiting | City of Hope Medical Center | 56 | 2026-02-11 | 2026-03-05 |
| Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors Fecal Microbiota Transplantation (FMT) - Ulcerative Colitis (UC), Inflammatory Bowel Disease | Phase 2 | Recruiting | First Affiliated Hospital of Kunming Medical University | 200 | 2026-02-03 | 2026-09-15 |
| FMT in Triple Negative Breast Cancer Guided by ctDNA Fecal Microbiota Transplantation (FMT), No Intervention. - Breast Cancer | Phase 1 / Phase 2 | Not yet recruiting | Jewish General Hospital | 125 | 2026-02-01 | 2025-12-18 |
| Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia Fecal microbiota transplantation - Immune Thrombocytopenia (ITP) | Phase 2 | Active not recruiting | Peking University People's Hospital | 42 | 2026-01-10 | 2026-07-29 |
| Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab Fecal microbiota transplantation (FMT), Atezolizumab & Bevacizumab - Hepato Cellular Carcinoma (HCC) | Phase 2 | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 15 | 2026-01-01 | 2026-06-01 |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) Fecal microbiota transfer, Vancomycin Oral Capsule, Atezolizumab + Bevacizumab - Immunotherapy, HCC - Hepatocellular Carcinoma | Phase 2 | Recruiting | Michael Dill | 48 | 2025-07-16 | 2025-08-06 |
| Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis MBK-01 - Diverticulitis, Diverticulitis of Sigmoid | Phase 2 | Recruiting | Mikrobiomik Healthcare Company S.L. | 81 | 2025-04-03 | 2025-06-05 |
| Fecal Microbiota Transplantation for Radiation-Induced Proctopathy Fecal Microbiota Transplantation Capsule - Radiation Induced Proctitis | Phase 2 | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 20 | 2025-02-01 | 2026-10-28 |
Showing 20 of 135. Sign in to see all of them.
Colitis, Ulcerative (21) · Clostridium Infections (11) · Inflammatory Bowel Diseases (10) · Irritable Bowel Syndrome (8) · Crohn Disease (7) · Hepatic Encephalopathy (4) · Obesity (4) · Autism Spectrum Disorder (3) · Carcinoma, Non-Small-Cell Lung (3) · Colitis (3) · Graft vs Host Disease (3) · Melanoma (3) · Carcinoma, Hepatocellular (2) · Cholangitis, Sclerosing (2) · Depression (2)
University of Alberta (6) · Brigham and Women's Hospital (4) · First Affiliated Hospital of Chengdu Medical College (4) · Jinling Hospital, China (3) · M.D. Anderson Cancer Center (3) · McMaster University (3) · Tel-Aviv Sourasky Medical Center (3) · University of Wisconsin, Madison (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Air Force Military Medical University, China (2) · Assaf-Harofeh Medical Center (2) · Chang Gung Memorial Hospital (2) · Changzhou No.2 People's Hospital (2) · Emory University (2) · Guangzhou First People's Hospital (2)
United States (41) · China (30) · Canada (21) · Israel (9) · France (5) · Denmark (4) · Italy (4) · Netherlands (4) · Norway (3) · Poland (2) · Spain (2) · Taiwan (2) · Belgium (1) · Croatia (1) · Finland (1)
Dina Kao, MD (5) · Christine Lee, MD (2) · Herbert L DuPont, MD (2) · Jessica R Allegretti, MD, MPH (2) · Lawrence J Brandt, MD (2) · Nasia Safdar, MD, PhD (2) · Ning Li, MD (2) · Sonia Michail, MD (2) · Valerie Taylor, MD, PhD (2) · Xiaoan Li, Ph.D (2) · Alan C Moss, MD PhD (1) · Alexander Khoruts, MD (1) · Alice H Christensen, MD, PhD (1) · Amin M Alousi (1)
PMID 21871249, PMID 25836986, PMID 25857665, PMID 26363929, PMID 26590773, PMID 26757463, PMID 27547925, PMID 28011612, PMID 29100842, PMID 29183074, PMID 29980607, PMID 30616014, PMID 30972640, PMID 31272391, PMID 31301451, PMID 31326345, PMID 31954100, PMID 32150549, PMID 32282545, PMID 32511695, PMID 32955197, PMID 32991818, PMID 33064186, PMID 33420959, PMID 33501942, PMID 33542131, PMID 34168032, PMID 34848167, PMID 35083238, PMID 35313729, PMID 35384391, PMID 35387830, PMID 35962454, PMID 36464584, PMID 36585700, PMID 37130682, PMID 37235836, PMID 37654670, PMID 38215933, PMID 39109266, PMID 39281978, PMID 39441941, PMID 39491858, PMID 39530534, PMID 39863610, PMID 39900089, PMID 39938959, PMID 40037667, PMID 40460824, PMID 40890737
2023 (3), 2014 (1), 2019 (1), P30CA016672 (1), P30CA033572 (1), P50CA221707 (1), R01AA029398 (1), R01DK128257 (1), U01AI125053 (1), U54CK000601 (1)